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Abstract
Background: Diagnosis of neonatal infection is difficult, because of it's non-specific clinical presentation and the lack 
of reliable diagnostic tests. The purpose of this study was to examine the potential diagnostic value of serum soluble 
intercellular adhesion molecule-1 (sICAM-1), soluble E-selectin (sE-selectin), highly sensitive C-reactive protein (hsCRP) 
and serum amyloid A (SAA) measurements, both individually and in combination in the setting of a neonatal intensive 
care unit.
Methods: 219 consecutive serum samples were taken from 149 infants undergoing sepsis work up in a neonatal 
intensive care unit. Clinical diagnosis was established in a prospective manner, blind to the results of the study 
measurements. Infants were classified by an experienced paediatrician as infected or not-infected, one week after 
presentation. Classification was based on clinical presentation, routine laboratory and radiological investigations and 
response to therapy. The infected group were sub-classified as (a) culture positive infection or (b) culture negative 
infection. sICAM-1, sE-selectin, hsCRP and SAA levels were determined from stored serum samples after diagnosis was 
established. Further sub-group analysis of results was undertaken according to early or late onset of infection and 
preterm or term status. Statistical analysis utilised Mann Whitney U test and ROC curve analysis.
Results: There were significantly increased serum levels of sICAM-1, hsCRP, E selectin (p < 0.001) and SAA (p = 0.004) in 
infected infants compared with non-infected. ROC curve analysis indicated area under the curve values of 0.79 (sICAM-
1), 0.73 (hsCRP), 0.72 (sE-selectin) and 0.61 (SAA). ROC curve analysis also defined optimum diagnostic cut-off levels for 
each measurement. The performance characteristics of sICAM-1, hsCRP and sE-selectin included a high negative 
predictive value (NPV) for culture positive infection and this was enhanced by combination of all 4 measurements. 
Clinical subgroup analysis suggested particularly high NPV for early onset symptoms, however further studies are 
required to elucidate this finding.
Conclusions: All four study measurements demonstrated some diagnostic value for neonatal infection however 
sICAM-1, hsCRP and sE-selectin demonstrated the highest NPV individually. The optimum diagnostic cut off level for 
hsCRP measurement in this study was much lower than currently used in routine clinical practice. Use of a combination 
of measurements enhanced diagnostic performance, demonstrating sensitivity of 90.3% and NPV of 91.3%. This study 
suggests there may be value in use of several of these markers, individually and in combination to assist in excluding 
neonatal infection. Further work is needed to confirm a specific role in the exclusion of early onset infection.Edgar et al. BMC Pediatrics 2010, 10:22
http://www.biomedcentral.com/1471-2431/10/22
Page 2 of 16
Background
The diagnosis of infection in preterm infants is difficult,
both because of the non-specific clinical presentation and
the lack of reliable diagnostic tests [1]. As a result of this
uncertainty, antimicrobial chemotherapy is often com-
menced on the slightest clinical suspicion of infection.
This approach, whilst effective in combating acute infec-
tion, increases the risks of drug side effects and the emer-
gence of drug resistant organisms within neonatal units.
Over recent years there has been great interest in the
potential diagnostic value of a range of haematological,
and immunological surrogate markers of infection [1,2].
The value of physiological measurements in this context
has also recently been examined [3].
C reactive protein (CRP) is a component of the innate
immune system and increased levels of CRP are observed
early in response to severe bacterial infection. As a classi-
cal acute phase reactant, however, CRP elevation alone
has insufficient specificity for diagnosis of neonatal infec-
tion. Our previous studies indicated that CRP > 6 mg/l
and sICAM-1> 300 ng/ml in plasma samples collected in
endotoxin free conditions [4,5] were independent predic-
tors of infection with a high sensitivity for clinical infec-
tion (95%) and NPV of 97%[4,5]. However such sampling
methods are impractical in routine practice and we sub-
sequently demonstrated in a retrospective study, that
routinely collected serum samples gave very similar mean
levels of sICAM-1[6]. It has also been demonstrated,
independent of those studies, that hsCRP measurement
below 1 mg/l provides increased sensitivity for neonatal
infection [7]. As most diagnostic laboratories do not pro-
vide hsCRP measurement, the optimum diagnostic cut
off level for CRP/hsCRP remains a matter of debate. E-
selectin is a cell adhesion molecule expressed and
secreted by activated endothelial cells and is a component
of an adhesion cascade that leads to leukocyte and plate-
let accumulation at sites of inflammation, infection, and/
or injury. Levels of soluble E-selectin (sE- selectin) have
also been previously documented in neonatal sepsis[8].
Serum Amyloid A (SAA) is also an acute phase protein
which has been shown to be of potential diagnostic value
in neonatal infection [9].
In this study, we sought to confirm and extend our ear-
lier findings, utilising blood samples drawn in a prospec-
tive study, at the time of acute clinical deterioration and
prior to antibiotic administration. We chose this time to
reflect the moment at which clinicians would require
additional laboratory information to guide their decision
regarding whether or not, to prescribe antibiotics and
were particularly interested to establish whether the high
negative predictive values previously obtained were
reproduced. Clinical diagnosis was established, by an
experienced paediatrician looking after the infants,
blinded to the results of the test measurements.
The incorporation of serum amyloid A, sE-selectin and
low level hsCRP (< 1 mg/l) in the study, was to establish
whether these measurements would enhance diagnostic
performance. Specifically, low level hsCRP measurement
was included to ascertain whether a new (lower) diagnos-
tic cut off level would be appropriate in this age group
rather than the more commonly used level of < 6 mg/l.
We report here the outcome of this study, in particular
the performance characteristics of each study measure-
ment regarding the diagnosis of neonatal infection.
Methods
Premature infants undergoing neonatal intensive care in
the Department of Neonatal Medicine, Queen's Medical
Centre, Nottingham, England were studied prospectively.
This is a regional referral centre based in a University
Teaching Hospital which receives infants both from the
hospital's obstetric unit and surrounding district general
hospitals. At the time of study it received approximately
400 admissions per year.
Infants were recruited consecutively, as they developed
acute clinical deterioration. At the time of enrolment into
the study, an enrolment form was completed indicating
the infant's age, underlying diagnosis, symptoms indica-
tive of acute deterioration, investigations undertaken and
therapy (if any) commenced. A peripheral venous blood
sample (0.5-1.0 ml) was taken into a plain bottle prior to
the administration of antibiotics and transported rou-
tinely to the laboratory. Serum was then separated and
stored at -30°C until later batch analysis. There were no
special storage/handling requirements. Venous blood
samples were also taken at the time of routine venepunc-
ture from a number of infants undergoing intensive care
with no acute signs of deterioration, as controls.
One week after deterioration, the routinely available
investigative results and subsequent clinical course were
reviewed (by VG & DE). Investigations commonly used
included e.g. full blood count, differential white count, C-
reactive protein (>10 mg/L), urine, blood or swab culture,
chest or abdominal X-ray and lumbar puncture Infants
were classified as infected or non-infected. Clinical out-
come beyond one week was not recorded.
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Infants were regarded as not infected if (i) their clinical
deterioration was transient (ii) a specific non infective
cause for the deterioration was identified (iii) there was
no haematological, microbiological or radiological evi-
dence of infection and (iv) administration of antibiotics
did not result in clinical improvement. The infected
group were sub-classified as (a) culture positive infection
or (b) culture negative infection, based on the identifica-
tion of any positive microbiological results from blood,
urine, skin, CSF or other cultures. The culture negative
infection subgroup included infants in whom there was
either haematological or radiological evidence of infec-
tion or those who responded significantly to administra-
tion of antibiotics. Study measurements (including
hsCRP) were not available to the investigators when allo-
cating infants into their groups.
A standardised "panel" of investigations was not used
for all infants; rather, investigations were tailored to each
individual presentation by the clinician in charge. The
investigations undertaken for each infant were recorded.
Table 1: Gestational age & diagnosis requiring care in NICU
Diagnosis Infected (n = 74) Not Infected (n = 114) Controls (n = 27)
Prematurity/LBW/VLBW/IUGR 33 65 17
Respiratory difficulty
(pneumonia, RDS, TTN, BPD, 
asphyxia, pneumothorax)
23 44 5
NEC/GI obstruction/seizures/
jaundice/skin necrosis
770
Congenital malformation 7 3 3
Suspected infection 17 4 0
Peri-operative care 3 3 0
Haemorrhage/circulatory 
disturbance
(shock, APH, PIH, dehydration, 
twin-twin transfusion)
01 1 2
PROM, meconium staining, 
Placenta praevia
11 14 0
Gestational Age
Median 29.0 32.0 32.0
25th quartile 27.0 29.0 28.25
75th quartile 35.0 36.0 34.0
Abbreviations:
RDS: respiratory distress syndrome, NEC: necrotising enterocolitis, PROM: premature rupture of membranes, TTN: transient tachypnoea of the 
newborn, VLBW: very low birth weight, BPD: bronchopulmonary dysplasia, IUGR: intrauterine growth retardation, PIE: pulmonary interstitial 
emphysema, APH:ante partum haemorrhage, PIH: primary intracerebral haemorrhageEdgar et al. BMC Pediatrics 2010, 10:22
http://www.biomedcentral.com/1471-2431/10/22
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The identification of positive skin swabs, in the absence
of any clinical deterioration was insufficient to have an
infant classified as infected. Urine samples were obtained
by supra-pubic aspiration and lumbar puncture was per-
formed if the clinician felt this was indicated. Interpreta-
tion of chest X-ray sought to identify any new areas of
pneumonic change. Abdominal X ray was used to identify
potential signs of intestinal obstruction or perforation.
Control samples were taken for comparative purposes,
however the data from these samples were not utilised in
the calculation of diagnostic performance of the test mea-
surements.
sICAM-1 and sE-selectin levels were measured by com-
mercial ELISA (R&D Systems Europe Ltd, Abingdon UK),
hsCRP and SAA by highly sensitive automated immuno-
assays (Abbott IMx).
Statistical analysis utilised non-parametric tests
(Mann-Whitney U) from a computerised database (SPSS
11 for windows, © SPSS inc. 2001). Receiver operating
characteristic curves were plotted and analysed to com-
pare diagnostic performance and optimum diagnostic cut
off levels (Medcalc® version10.0.2.0 © Frank Schoonjans).
Table 2: Frequency of events prompting investigation for infection
Event Infected Not Infected
Unstable respiration 24 77
Unstable temperature 21 17
Rash 12 2
Bradycardia 10 3
Apnoea 6 4
Hypoglycaemia 4 21
Seizure 2 5
Tachycardia 3 1
Acidosis 2 0
Maternal UTI 0 1
Skin Infection 1 0
Smelly baby 0 2
Jaundice 0 2
Hypotension 0 3
Irritability 5 5
NEC 0 1Edgar et al. BMC Pediatrics 2010, 10:22
http://www.biomedcentral.com/1471-2431/10/22
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Figure 2 Classification of samples after one week.
118 not infected 
(83 preterm, 35 term) 
13 Early onset 
61 Late onset  33 culture negative  
(7 early, 26 late)
41 culture positive  
(6 early, 35 late)
74 Infected 
(62 preterm, 12 term) 
192 enrolled 
34 Late onset 
84 Early onset 
Figure 1 Initial classification at enrolment to the study.
219 
samples  97 Early onset 
95 Late onset 
27 Controls 
192 Study samples  
(145 preterm, 47 term) Edgar et al. BMC Pediatrics 2010, 10:22
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Consent
Written informed parental consent was obtained for this
study (VG).
Ethical Approval
Ethical approval for this study was obtained from the Eth-
ics Committee, University Hospital, Queen's Medical
Centre, Derby Road, Nottingham, England.
Results
Clinical characteristics of study population
219 samples were obtained from 149 infants. 27/219
(13%) of these were control samples and 192/219 were
taken from infants who had an acute clinical deteriora-
tion.
145/192 samples were from preterm infants (<36 weeks
gestation) and 47/192 from term infants (>36 weeks ges-
tation). 97/192 (50.5%) were suspected of early onset
infection (<48 hours after delivery) and 95/192 (49.5%) of
late onset infection (> 48 hours after delivery: Figure 1).
Gestational age range was from 24-41 weeks. Mean gesta-
tional ages and underlying diagnoses that triggered
admissions to the neonatal intensive care unit (NICU) are
summarised (Table 1). The nature of clinical deteriora-
tion prompting investigation for infection and enrolment
Table 3: Non infectious causes of clinical deterioration identified in the not-infected infants (n = 118)
Cause N Cause N
RDS 30 Fetomaternal transfusion 2
TTN 18 PROM 2
Unknown 12 IVH 2
Prematurity 7 Hypoglycaemia 2
BPD 7 Hypoxic encephalopathy 2
Secondary apnoea 7 Pneumothorax 1
Asphyxia 5 Steroid leucocytosis 1
GI Obstruction 4 Skin necrosis 1
Dehydration 3 Drug withdrawal 1
IUGR 3 Post operative 1
Meconium staining 2 Duodenal atresia 1
Maternal infection 2 Hypotension 1
Teratoma 1
Total 118
Abbreviations:
RDS: respiratory distress syndrome, TTN: transient tachypnoea of the newborn, BPD: bronchopulmonary dysplasia, IUGR: intrauterine growth 
retardation, PROM: premature rupture of membranes IVH: intraventricular haemorrhage.Edgar et al. BMC Pediatrics 2010, 10:22
http://www.biomedcentral.com/1471-2431/10/22
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in the study are summarised in Table 2. The most com-
mon presenting clinical feature that triggered sepsis work
up was instability of respiration or temperature.
In terms of "routine" investigations, the following were
recorded as undertaken: full blood count (207), CRP
(219) blood culture (174), chest x-ray (111), abdominal x-
ray (34), urine culture (34), surface swabs (26), lumbar
puncture (17), endotracheal tube tip culture (18), gastric
aspirate (14), long line culture (8), CT scan (8), amniotic
fluid culture (4) and high vaginal swab (4).
74/192 (38.5%) samples were clinically classified as
infected. 118/192 (61.4%) samples as not infected. 62/74
(83.7%) of infected samples were from preterm infants
with 12/74 (16.2%) from term infants. 13/74 (17.6%) were
early onset and 61/74(82.4%) were late onset. These
included, 41/74 (55.4%) classified as culture positive epi-
sodes. 6 of these were early onset (2 pre-term and 4 term)
and 35 late onset (31 preterm and 4 term). 33/74 (44.6%)
samples were classified as culture negative episodes. 7 of
these were early onset (5 preterm and 2 term) and 26 late
onset (24 preterm and 2 term) (Figure 2).
Microorganisms identified
Microorganisms identified in the culture positive infec-
tion subgroup (n = 41) included Staphylococcus epider-
midis (15: 2 early onset, 13 late onset), Coliforms (6: 1
early onset, 5 late onset), Group B Streptococcus (5: 2
early onset, 3 late onset), Staphylococcus aureus (5: all late
onset), Enterococcus gallium (4: all late onset), Streptococ-
cus viridans (3: all late onset), other gram positive cocci
(2: 1 early onset, 1 late onset), Haemophilus influenzae (1:
late onset).
In 2/33 culture negative infection samples there was
identification of Enterococcus gallium (1) and Coliforms
(1) from swabs which were regarded as non-pathogenic
contamination.
118/192 (61.4%) samples were taken during episodes
which, with the benefit of one weeks clinical observation
and the results of investigation, were deemed to be non-
infectious. 82 of these samples were taken for early onset
and 36 for late onset symptoms. In 7/118 cases there was
positive cultures regarded as non-pathogenic contamina-
tion. (Group B Streptococcus (1), Staphylococcus epider-
midis(3), Enterococcus gallium(1), and Coliforms (2)). For
Table 4: Study measurements in the clinical groups
Clinical group Controls
(n = 27)
Not Infected 
(n = 118)
Infected (n = 74)
Culture positive 
(n = 41)
Culture Negative 
(n = 33)
Duration of 
antibiotic therapy 
(days)
0
(0,0)
2
(1,3)
5
(5,7)
7
(5,7)
5
(5,7)
sICAM-1 (ng/ml), 165 (130,290) 168
(140,228)
341
(236,554)
P < 0.001
405 (252,666)
P < 0.001
306 (230,484)
P < 0.001
hsCRP(mg/l), 0.1 (0.1,0.4) 0.1
(0.1,0.7)
0.85 (0.3,15.9)
P < 0.001
2.0 (0.7,21.2)
P < 0.001
0.45 (0.1,2.2)
P = 0.012
SAA(mg/l) 0.9 (0.9,1.0) 1.0
(0.9,2.0)
1.5
(0.9,5.8)
P = 0.004
2.0
(1.0-10.0)
P = 0.001
1.0
(0.9,2.0)
P > 0.05
sE-selectin(ng/ml) 71 (51,118) 90
(59,124)
135
(94,192)
P < 0.001
158 (94,207)
P < 0.001
109 (92,184)
P = 0.009
Levels of test measurements in each clinical group and duration of antibiotic therapy is provided. All data quoted as (median, (1st, 3rd 
quartiles)).
Statistical comparison between infected and not infected groups (Mann Whitney U test). Highly significant elevations (P < 0.001)are 
highlighted in bold. Control samples not included in statistical analysis.Edgar et al. BMC Pediatrics 2010, 10:22
http://www.biomedcentral.com/1471-2431/10/22
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these 118 episodes an alternative explanation, other than
infection, was required to explain the acute clinical dete-
rioration and these causes are summarised (Table 3).
Use of antibiotics
Duration of antibiotic therapy was recorded as a surro-
gate marker of the clinical diagnosis of infection. The
maximum duration of antibiotic therapy was 20 days in
the culture positive infection subgroup and 10 days in the
culture negative infection subgroup. Only one infant in
the culture positive infection subgroup was treated for
less than 5 days, he died from septicaemia within 24
hours and duration of therapy was therefore recorded for
only one day. Five infants in the culture negative infection
subgroup were treated for between 2 and 4 days. A single
infant in the culture negative infection subgroup was not
treated with antibiotics. This was because the diagnosis
of culture negative meningitis was only made retrospec-
tively when the infant presented with hydrocephalus
some 4 weeks later. 82 infants subsequently classified as
not infected were prescribed antibiotics. In 52 these were
stopped at 48 hours with 18 receiving 5 days treatment.
Summary details of antibiotic therapy duration are pro-
vided along with test data (Table 4).
Results of test measurements in the clinical subgroups
The distribution of the test measurements (sICAM-1,
hsCRP, SAA and sE-selectin) was positively skewed and
therefore median and 1st & 3rd quartile values are pro-
vided for these in each study subgroup (controls(27), not
infected(118), infected(74), and culture positive(41) and
negative (33) subgroups. Table 4).
The Mann Whitney U test was used to compare the
distribution of measurements between the infected and
not infected groups. There was no significant difference
for any test measurement between the not-infected (n =
118) and the control (n = 27) groups. The infected group
was compared to the not infected group, and culture pos-
itive and negative subgroups were also compared to the
not infected group. Control samples were not utilised in
any comparison with samples from infected infants.
There was a highly significant elevation of sICAM-1,
hsCRP and sE-selectin (p < 0.001) in both the infected
group, and culture positive subgroup, compared with the
not infected. SAA was significantly elevated in both
groups (infected p = 0.004 and culture positive p = 0.001).
For the culture negative subgroup, there was a highly sig-
nificant elevation of sICAM-1 (p < 0.001), and significant
elevation of sE-selectin (p = 0.009) and hsCRP (p =
Figure 3 Receiver operating characteristic (ROC) curve for all test measurements in the diagnosis of infection.
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SensitivityEdgar et al. BMC Pediatrics 2010, 10:22
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0.012), but no significant increase in levels of SAA (p >
0.05).
Because some infants suffered repeated deteriorations
and were enrolled in the study on several occasions, we
further analysed the data to include only one sample/epi-
sode per infant. For this analysis, only the first sample
from each infant was accepted and the numbers in each
group were as follows: control 13, not- infected 89,
infected 46 (culture positive 26, culture negative 20)
(Table 5). There remained a highly significant increase in
sICAM-1, hsCRP and sE-selectin (p < 0.001) in the
infected and culture positive subgroup. There was a less
significant increase in SAA in the infected (p = 0.021) and
culture positive infection subgroup (p = 0.007) compared
to and the not-infected. For the culture negative sub-
group there was a significant elevation of sICAM-1 (p <
0.001) and hsCRP (p = 0.017) but no significant difference
for SAA (p > 0.05) and sE- selectin (p > 0.05).
ROC Curve analysis
Receiver operating characteristics (ROC) curve analysis
was utilised to assess diagnostic performance of tests.
The area under the curve (AUC) gives an estimate of the
percentage of cases correctly classified by the test and
values as close as possible to 100% are desirable. The
comparative ROC curves for all four measurements for
the diagnosis of infection (Figure 3) and for the diagnosis
of culture positive infection subgroup (Figure 4) are pro-
vided.  R OC cu rve  a nal ys is  of  da ta  u ti lis ing  onl y s ingle
samples from each infant produced no significant differ-
ence in the curves (data not shown). Detailed figures for
AUC and other measurements of diagnostic performance
(sensitivity, specificity, positive and negative predictive
values) are provided in Tables 6 &7. The study popula-
tions are also further subdivided and diagnostic perfor-
mance figures provided for early and late onset infection
and preterm and term infants.
The ranking of the tests for diagnosis of all infection by
area under the curve was sICAM-1 = 0.79, hsCRP = 0.73,
sE-selectin = 0.72, SAA = 0.61 (Table 6). Ranking order of
tests was identical and AUC almost identical (sICAM-1 =
0.78, hsCRP = 0.78, sE-selectin = 0.72, SAA = 0.68) for
the diagnosis of culture positive infection (Table 7). Opti-
mum diagnostic "cut-off" levels were identified from the
ROC curves for sICAM-1 (> 228 ng/ml), hsCRP (> 0.4
mg/l) sE-selectin (>132 ng/ml) and SAA (>1 mg/l) (Table
Figure 4 Receiver operating characteristic (ROC) curve for all test measurements in the diagnosis of culture positive infection.
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Table 6: Diagnostic performance of study measurements
Infected
All Early onset Late Onset Preterm Term
sICAM-1 n = 73 n = 12 n = 61 n = 62 n = 11
AUC 0.79 0.56 0.66 0.80 0.65
Optimum cut off 228 ng/ml 228 ng/ml 368 ng/ml 228 ng/ml 203 ng/ml
sensitivity 76.7% 33.3% 52.5% 82.3% 54.6%
specificity 75.6% 95% 72.2% 70.4% 82.4%
Positive 
predictive value
66.6% 50.3% 76.1% 68.0% 54.6%
Negative 
predictive value
83.6% 90.35% 47.4% 83.8% 82.4%
hsCRP n = 72 n = 13 n = 59 n = 60 n = 12
AUC 0.73 0.74 0.64 0.73 0.78
Optimum cut off 0.4 mg/l 0.6 mg/l 0.4 mg/l 0.2 mg/l 0.4 mg/l
sensitivity 69.4% 61.5% 71.2% 75% 83.3%
specificity 70.4% 82.3% 55.6% 65.6% 63.6%
Positive 
predictive value
59.5% 36.3% 71.2% 61.4% 45.4%
Negative 
predictive value
78.6% 92.8% 55.6% 78.2% 91.3%
SAA n = 68 n = 12 n = 56 n = 57 n = 11
AUC 0.61 0.66 0.59 0.59 0.69
Optimum cut off 1 mg/l 1 mg/l 3 mg/l 5 mg/l 1 mg/l
sensitivity 23.5% 58.3% 28.6% 24.6% 81.8%
specificity 92.8% 67.1% 91.4% 92.4% 59.4%Edgar et al. BMC Pediatrics 2010, 10:22
http://www.biomedcentral.com/1471-2431/10/22
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Positive 
predictive value
66.6% 21.8% 84.2% 70.0% 40.9%
Negative 
predictive value
66.5% 91.1% 44.5% 62.9% 90.5%
sE-selectin n = 62 n = 12 n = 50 n = 52 n = 10
AUC 0.72 0.69 0.67 0.77 0.65
Optimum cut off 132 mg/l 161.7 mg/l 91.5 mg/l 91.5 mg/l 204 mg/l
sensitivity 54.8% 50.0% 71.2% 78.9% 50.0%
specificity 82.3% 93.9% 54.8% 67.2% 93.1%
Positive 
predictive value
66.6% 60.2% 71.7% 65.1% 71.3%
Negative 
predictive value
73.8% 91.0% 54.1% 80.4% 84.4%
All infected infants: Area under curve (AUC), optimum diagnostic "cut off" level and diagnostic performance statistics derived from ROC curve 
analysis for each test measurement for all infected infants and subcategories defined as early/late onset symptoms, and preterm/term 
infants.
Table 6: Diagnostic performance of study measurements (Continued)
6). Diagnostic performance figures are also provided for a
combination of all test measurements (Table 8) and for a
combination of sICAM-1 and hsCRP (Table 9)
Discussion and Conclusions
This prospective study was designed to confirm the
hypothesis that measurement of sICAM-1 in routinely
collected serum samples was of diagnostic value in neo-
natal infection. We also wished to test the additional
value of low level hsCRP, serum amyloid A (SAA) and sE-
s e l e c t i n  m e a s u r e m e n t s  a s  s t u d i e s  b y  o t h e r  g r o u p s  h a d
suggested these may have clinical utility.
Since this study was commenced, Ng has made recom-
mendations for optimum study design [10] the majority
of which we fulfilled. This study was prospective, infants
were recruited consecutively, and criteria for inclusion in
the study are documented. The definition of infection
was "infected" versus "non-infected" with the former sub-
divided into "culture positive" and "culture negative"
infection subgroups. Data analysis included use of ROC
curves and calculation of predictive values. The two areas
where we departed from Ng's guidelines were (i) includ-
ing early and late onset infection and preterm and term
infants and (ii) allowing more than one episode of clinical
infection per infant.
With regard to the first point, analysis of our data indi-
cates that we recruited almost exactly 50% early and 50%
late onset infection (Figure 1). However, confirmation of
early onset infection was much less common (13/97) than
late onset disease (61/95) (Figure 2). We have provided
separate diagnostic performance figures for these sub-
groups in Tables 6 &7, however because the numbers of
term infants and early onset infection in the infected
group are both small, the diagnostic performance data for
these subgroups should be interpreted cautiously. In rela-
tion to point (ii) we did include more than one suspected
infected episode per infant, however data analysis did not
indicate any significant effect on the results obtained as a
result (Tables 4 &5).
Finally, Ng also recommended the future use of multi-
plexed analysis of multiple measurements for the diagno-
sis of neonatal infection. The data presented here
supports the use of a combination of test to improve diag-
nostic performance and we have recently published stud-
ies supporting that view [11].
With regard to recruitment in this study, we believe
that the range of underlying diagnoses requiring admis-
sion to intensive care, the symptoms triggering investiga-
tion and organisms identified are consistent with routine
clinical practice. 27 control samples were obtained fromEdgar et al. BMC Pediatrics 2010, 10:22
http://www.biomedcentral.com/1471-2431/10/22
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Table 7: Diagnostic performance of study measurements for culture positive infection
Culture positive infection
All Early onset Late Onset Preterm Term
sICAM-1 n = 40 n = 5 n = 35 n = 33 n = 7
AUC 0.78 0.57 0.65 0.81 0.56
Optimum cut off 249 ng/ml 228 ng/ml 504 ng/ml 249 ng/ml 170 ng/ml
sensitivity 77.5% 40.0% 48.6% 87.9% 71.4%
specificity 66.9% 93.0% 79.0% 60.0% 55.3%
Positive 
predictive value
38.7% 25.0% 56.7% 39.7% 22.7%
Negative 
predictive value
91.7% 96.4% 73.1% 94.3% 91.3%
hsCRP n = 40 n = 6 n = 34 n = 32 n = 8
AUC 0.78 0.81 0.71 0.79 0.72
Optimum cut off 0.6 mg/l 0.6 mg/l 0.6 mg/l 0.6 mg/l 0.4 mg/l
sensitivity 80% 83.3% 79.4% 81.2% 87.5%
specificity 71.4% 80.2% 59.0% 73.6% 59.5%
Positive 
predictive value
43.2% 22.7% 51.9% 47.3% 31.8%
Negative 
predictive value
92.9% 98.6% 83.7% 93.1% 95.7%
SAA n = 36 n = 5 n = 31 n = 29 n = 7
AUC 0.68 0.74 0.67 0.68 0.65
Optimum cut off 1 mg/l 1 mg/l 0.9 mg/l 3 mg/l 1 mg/l
sensitivity 63.9% 80.0% 77.4% 41.4% 85.7%
specificity 64.3% 47.0% 46.7% 86.9% 55.6%Edgar et al. BMC Pediatrics 2010, 10:22
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Positive 
predictive value
31.1% 12.5% 42.9% 46.2% 27.3%
Negative 
predictive value
87.6% 98.2% 80.0% 84.5% 95.2%
sE-selectin n = 33 n = 5 n = 28 n = 27 n = 6
AUC 0.72 0.77 0.66 0.79 0.52
Optimum cut off 132 mg/l 162 mg/l 116 mg/l 132 mg/l 224 mg/l
sensitivity 63.6% 60.0% 67.9% 66.7% 33.3%
specificity 76.0% 90.3% 62.3% 79.4% 87.9%
Positive 
predictive value
41.2% 30.0% 48.7% 48.6% 40.0%
Negative 
predictive value
88.8% 97.0% 78.6% 89.0% 88.2%
Culture positive infected infants: Area under curve (AUC), optimum diagnostic "cut off" level and diagnostic performance statistics derived 
from ROC curve analysis for each test measurement for culture positive infected infants and subcategories defined as early/late onset 
symptoms, and preterm/term infants.
Table 7: Diagnostic performance of study measurements for culture positive infection (Continued)
infants undergoing intensive care who were clinically sta-
ble. It was reassuring that no significant difference was
found in the levels of any of the study measurements
between these samples and the 118 samples obtained
from infants identified as not infected. This suggests that
these measurements are not subject to non-specific mod-
ulation by routine intensive care processes. It is impor-
tant to note however that these control samples were not
utilised in any further statistical analysis.
Classification of infants as infected or not-infected is at
times difficult and we have endeavoured to be as clear as
possible in how we approached this process which is cru-
cial to evaluating our study. We believe that strength of
this study is that the classification of infants as infected or
not infected was made by an experienced paediatrician
directly involved in the care of the infants in the light of
one weeks follow up after the initial presentation with
acute clinical deterioration. Classification was made in
the knowledge of the routinely available investigations
but blinded to the study results. As highlighted in the
results section, the identification of a positive culture
from a biological sample was insufficient of itself to result
in the classification of an infant as infected. We have pro-
vided the non-infectious causes of acute clinical deterio-
ration, where this was identifiable and also included
duration of antibiotic therapy as a surrogate marker of
infection status. A number of clinical factors and routine
investigations were taken into account in classification,
however we must recognise that this is to some extent an
inexact science and despite our best efforts, it is always
possible for a small number of infants to have been mis-
classified.
All four study measurements were significantly ele-
vated in the infected samples (n = 74) compared with the
non-infected (n = 118) and controls (n = 27). This sug-
gested that all four may have some diagnostic utility. In
considering diagnostic performance, we preferentially
utilised AUC as an indicator of the percentage of infants
correctly classified and from this confirmed the optimum
diagnostic cut off level as the point on the curve closest to
the upper left corner, providing maximum sensitivity and
s p e c i f i c i t y .  H o w e v e r ,  l a b o r a t o r y  t e s t s  m a y  b e  u s e d  t o
identify or to exclude a diagnosis and the mode of use
would affect the selection of a diagnostic cut off level. It is
important to remember that as different cut off points are
used and sensitivity of an assay increases, in most cases
specificity falls, leading to increased "false positive"
results and vice-versa.
SAA measurement was the least significantly elevated
in the infected samples (p = 0.004) overall and ROC curveEdgar et al. BMC Pediatrics 2010, 10:22
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analysis confirmed SAA as the least discriminatory of the
four study measurements (AUC 0.61). sE-selectin mea-
surement was highly significantly elevated in both the
infected samples overall and the culture positive sub-
group (both p < 0.001) as was hsCRP measurement. ROC
curve analysis indicated that hsCRP measurement was
slightly more discriminating than sE-selectin for both
overall infection (AUC 0.73 vs 0.72) and the culture posi-
tive infection subgroup (AUC 0.78 vs 0.72).
The optimum diagnostic cut-off for hsCRP was 0.4 mg/
l for infection and 0.6 mg/l for the culture positive infec-
tion subgroup. This confirms earlier work indicating that
low level hsCRP measurement is of diagnostic value and
therefore diagnostic laboratories should consider provid-
ing this more sensitive assay in this clinical situation [7].
Table 8: ROC curve analysis statistics for combination of all 4 test measurements
Infected
All Early onset Late onset Preterm Term
sICAM-1+hsCRP
+SAA+sE 
selectin
n = 62 n = 12 n = 50 n = 52 n = 10
AUC 0.84 0.72 0.74 0.84 0.78
sensitivity 90.3% 66.7% 66.0% 92.3% 60.0%
specificity 67.0% 87.3% 74.2% 69.2% 89.7%
Positive 
predictive value
64.4% 50.0% 80.5% 70.6% 66.7%
Negative 
predictive value
91.3% 93.2% 57.5% 91.8% 86.7%
Culture positive infection
All Early onset Late Onset Preterm Term
sICAM-1+hsCRP
+SAA+sE 
selectin
n = 33 n = 5 n = 28 n = 27 n = 6
AUC 0.84 0.82 0.75 0.87 0.63
sensitivity 84.8% 80.0% 50.0% 96.3% 33.3%
specificity 66.7% 82.9% 88.7% 65.6% 97.0%
Positive 
predictive value
40.6% 25.0% 70.0% 45.6% 66.7%
Negative 
predictive value
94.3% 98.3% 77.0% 98.3% 88.9%Edgar et al. BMC Pediatrics 2010, 10:22
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Finally, sICAM-1 measurement was highly significantly
elevated in both the infected samples overall and both the
culture positive and negative subgroups (all p < 0.001).
ROC curve analysis indicated that sICAM-1 measure-
ment correctly classified most infants in this study (AUC
0.79 for all infected samples and 0.78 for the culture posi-
tive subgroup).
ROC curve analysis of combinations of tests suggests
that this results in improved diagnostic performance for
neonatal infection.(Tables 8 &9). The combination of all 4
study measurements (Table 8) indicated highest AUC of
the study at 0.84 for both infection and the culture posi-
tive subgroup. The combination of sICAM-1 and hsCRP
measurement resulting in AUC of 0.81 and 0.79 for all
infection and the culture positive subgroup respectively.
An important finding in our previous work was that of
a high negative predictive value for infection for a combi-
nation of sICAM-1 and CRP. In this study, sICAM-1,
CRP and sE-selectin gave negative predictive value (NPV)
for infection of 83.6%, 78.6% and 73.8% respectively
(Table 6) These figures rose 91.7%, 92.9% and 88.8%
respectively for culture positive infection. The combina-
Table 9: ROC curve analysis statistics for combination of sICAM-1 + hsCRP measurements
Infected
All Early onset Late Onset Preterm Term
sICAM-1 + hsCRP n = 71 n = 12 n = 59 n = 60 n = 11
AUC 0.81 0.56 0.68 0.82 0.65
sensitivity 78.9% 33.3% 59.3% 85.0% 45.4%
specificity 75.9% 96.0% 69.4% 70.0% 90.6%
Positive 
predictive value
67.5% 57.1% 76.1% 68.0% 62.5%
Negative 
predictive value
85.0% 90.1% 51.0% 86.2% 82.9%
Culture positive infection
All Early onset Late Onset Preterm Term
sICAM-1 + hsCRP n = 39 n = 5 n = 34 n = 32 n = 7
AUC 0.79 0.583 0.68 0.82 0.57
sensitivity 71.8% 40.0% 52.9% 85.0% 71.4%
specificity 75.0% 95.2% 76.7% 70.0% 58.3%
Positive 
predictive value
43.7% 33.3% 58.1% 68.0% 25.0%
Negative 
predictive value
90.8% 96.3% 75.0% 86.2% 91.3%Edgar et al. BMC Pediatrics 2010, 10:22
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tion of all 4 measurements provides a NPV of 91.3% for
infection and 94.3% for culture positive infection in this
study (Table 8). These figures exceed the performance of
a combination of sICAM-1 and CRP alone (Table 9). The
analysis of diagnostic performance of the early/late onset
and preterm/term babies is of interest, despite the small
numbers involved. It appears there may be particular
value in these measurements in the exclusion of early
onset infection, however further studies specifically
designed to test this hypothesis would be required.
In this study we have therefore confirmed prospectively
that all four test measurements are significantly elevated
in the serum of infected infants. Results were obtained
from routinely collected samples. The optimum diagnos-
tic levels for these tests have been established and data
indicate that for CRP, this level is well below that which is
routinely available in diagnostic laboratories, suggesting
that the introduction of hsCRP assays should be consid-
ered. The use of combinations of several measurements
clearly has benefit in improving diagnostic performance
and in particularly assisting in the exclusion of infection
as a cause of acute clinical deterioration.
The ability to exclude infection in infants undergoing
intensive care is clinically extremely important. NPV lev-
els achieved in this study would be very helpful to the cli-
nician in making the decision as to whether it was safe to
withhold or discontinue antibiotic therapy. Further stud-
ies should focus on the use of combinations of likely can-
didate markers of infection to develop combinations
suitable for use in the acute neonatal intensive care set-
ting.
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